Free Trial

Bruker (BRKR) Stock Price, News & Analysis

+0.55 (+0.72%)
(As of 05/24/2024 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
773,100 shs
Average Volume
915,625 shs
Market Capitalization
$11.23 billion
P/E Ratio
Dividend Yield
Price Target

Bruker MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
10.0% Upside
$85.00 Price Target
Short Interest
3.42% of Float Sold Short
Dividend Strength
Based on Four Factors
Upright™ Environmental Score
News Sentiment
0.47mentions of Bruker in the last 14 days
Based on 27 Articles This Week
Insider Trading
Selling Shares
$1.35 M Sold Last Quarter
Proj. Earnings Growth
From $2.67 to $3.19 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.85 out of 5 stars

Computer And Technology Sector

29th out of 595 stocks

Analytical Instruments Industry

2nd out of 29 stocks

BRKR stock logo

About Bruker Stock (NASDAQ:BRKR)

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

BRKR Stock Price History

BRKR Stock News Headlines

Bruker (NASDAQ:BRKR) Lowered to Hold at
Peeling Back The Layers: Exploring Bruker Through Analyst Insights
Bruker (NASDAQ:BRKR) Releases FY 2027 Earnings Guidance
Bruker (NASDAQ:BRKR) Sees Large Volume Increase
Bruker Announces Quarterly Dividend
Here's what to expect from Bruker's earnings report
See More Headlines
Receive BRKR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bruker and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/15 Dividend
Dividend Payable
Last Earnings
Ex-Dividend for 6/17 Dividend
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Analytical instruments
Life Sciences Tools & Services
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
8 Analysts


Net Income
$427.20 million
Pretax Margin


Sales & Book Value

Annual Sales
$2.96 billion
Cash Flow
$3.57 per share
Book Value
$9.86 per share


Free Float
Market Cap
$11.23 billion

Social Links

10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Gerald N. HermanMr. Gerald N. Herman (Age 66)
    Executive VP & CFO
    Comp: $1.13M
  • Dr. Mark R. Munch Ph.D. (Age 62)
    Corporate Executive VP and President of Bruker Nano Group & Corporate
    Comp: $1.63M
  • Mr. Juergen Srega (Age 69)
    President of Bruker CALID Group & Bruker Daltonics Division
    Comp: $842.19k
  • Dr. Falko Busse Ph.D. (Age 57)
    President of Bruker BioSpin Group
    Comp: $945.18k
  • Dr. Frank H. Laukien Ph.D. (Age 64)
    Chairman, CEO & President
    Comp: $1.82M
  • Mr. Justin Joseph Ward
    Senior Director of Investor Relations & Corporate Development
  • Mr. J. Brent Alldredge J.D. (Age 49)
    General Counsel & Secretary
  • Stacey Desrochers
    Treasurer & Director of Investor Relations
  • Dr. Burkhard Prause Ph.D. (Age 57)
    President and CEO of Bruker Energy & Supercon Technologies, Inc.
    Comp: $595.96k

BRKR Stock Analysis - Frequently Asked Questions

Should I buy or sell Bruker stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" BRKR shares.
View BRKR analyst ratings
or view top-rated stocks.

What is Bruker's stock price target for 2024?

8 Wall Street research analysts have issued 12 month price targets for Bruker's shares. Their BRKR share price targets range from $72.00 to $102.00. On average, they expect the company's stock price to reach $85.00 in the next twelve months. This suggests a possible upside of 10.0% from the stock's current price.
View analysts price targets for BRKR
or view top-rated stocks among Wall Street analysts.

How have BRKR shares performed in 2024?

Bruker's stock was trading at $73.48 at the start of the year. Since then, BRKR shares have increased by 5.1% and is now trading at $77.25.
View the best growth stocks for 2024 here

When is Bruker's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 1st 2024.
View our BRKR earnings forecast

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) posted its quarterly earnings data on Thursday, May, 2nd. The medical research company reported $0.53 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.07. The medical research company earned $721.70 million during the quarter, compared to analyst estimates of $729.88 million. Bruker had a net margin of 13.38% and a trailing twelve-month return on equity of 27.31%. Bruker's revenue for the quarter was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.64 EPS.

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker announced a quarterly dividend on Wednesday, May 15th. Shareholders of record on Monday, June 3rd will be paid a dividend of $0.05 per share on Monday, June 17th. This represents a $0.20 annualized dividend and a dividend yield of 0.26%. The ex-dividend date is Friday, May 31st.
Read our dividend analysis for BRKR

Is Bruker a good dividend stock?

Bruker (NASDAQ:BRKR) pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.26%. The dividend payout ratio is 7.27%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BRKR will have a dividend payout ratio of 6.27% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BRKR.

What guidance has Bruker issued on next quarter's earnings?

Bruker issued an update on its FY 2027 earnings guidance on Friday, May, 17th. The company provided earnings per share guidance of 4.000-4.300 for the period. The company issued revenue guidance of $4.2 billion-$4.4 billion.

What is Frank H. Laukien's approval rating as Bruker's CEO?

126 employees have rated Bruker Chief Executive Officer Frank H. Laukien on Frank H. Laukien has an approval rating of 54% among the company's employees. This puts Frank H. Laukien in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 79.0% of employees surveyed would recommend working at Bruker to a friend.

What other stocks do shareholders of Bruker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include AbbVie (ABBV), CVS Health (CVS), Micron Technology (MU), Cisco Systems (CSCO), Intel (INTC), Alibaba Group (BABA), Walt Disney (DIS), Applied Materials (AMAT), Bank of America (BAC) and Bristol-Myers Squibb (BMY).

Who are Bruker's major shareholders?

Bruker's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (6.78%), TD Asset Management Inc (1.23%), Congress Asset Management Co. MA (1.03%), Price T Rowe Associates Inc. MD (0.73%), Janus Henderson Group PLC (0.60%) and Epoch Investment Partners Inc. (0.32%). Insiders that own company stock include Cynthia M Friend, Frank H Laukien, Gerald N Herman, Hermann Fritz Requardt, Marc A Kastner, Mark Munch and Richard A Packer.
View institutional ownership trends

How do I buy shares of Bruker?

Shares of BRKR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Bruker have any subsidiaries?
The following companies are subsidiares of Bruker: Accel Instruments, Advances Diagnostic Solutions Pty. Ltd., Agapetus GmbH, Alicona Corporation, Alicona GmbH, Alicona Imaging, Alicona Imaging GmbH, Alicona Korea Pcific Ltd., Alicona Manufacturing Inc., Alicona SARL, Alicona UK Limited, Alicona s.r.l., Anasys Instruments Corporation, Anasys Instruments GmbH, Arxspan, Biocentra AS., Bruker (Beijing) Scientific Technology Co. Ltd., Bruker (Malaysia) SDN BHD, Bruker AXS GmbH, Bruker AXS Handheld Inc., Bruker AXS LLC, Bruker AXS Ltd., Bruker Advanced Supercon GmbH, Bruker Austria GmbH, Bruker Belgium S.A./N.V., Bruker BioSciences Securities Corporation, Bruker BioSpin AG, Bruker BioSpin Corporation, Bruker BioSpin GmbH, Bruker BioSpin K.K., Bruker BioSpin MRI GmbH, Bruker Business Support Center sp. z o.o, Bruker Daltonics GmbH, Bruker Daltonics Ltd., Bruker Daltonics Pty. Ltd., Bruker Daltonics S.r.l., Bruker Daltonik GmbH, Bruker Detection Corporation, Bruker EAS GmbH, Bruker Energy & Supercon Technologies Inc. , Bruker Espanola S.A., Bruker Finance B.V., Bruker France S.AS., Bruker HTS GmbH, Bruker India Scientific PVT Ltd., Bruker Invest AG, Bruker Italia S.r.l., Bruker JV Israel Ltd., Bruker JV UK Ltd., Bruker Korea Co. Ltd., Bruker Ltd., Bruker Mexicana S.A. de C.V., Bruker MicroCT N.V., Bruker Nano GmbH, Bruker Nano Inc., Bruker Nederland B.V., Bruker Nordic AB, Bruker OST LLC, Bruker Optics GmbH, Bruker Optics Inc. , Bruker Optik GmbH, Bruker PTY Ltd., Bruker Physik GmbH, Bruker Polska Sp. Z o.o., Bruker Portugal Unipessoal LDA, Bruker Scientific Instruments Hong Kong Co. Ltd., Bruker Scientific Israel Ltd., Bruker Scientific LLC, Bruker Singapore Pte. Ltd., Bruker South Africa (Pty) Ltd., Bruker Taiwan Co. Ltd., Bruker Turkey Teknolojik Sistemler Ticaret Ltd. Sirketi, Bruker UK Ltd., Bruker do Brasil Ltda., Bruker s.r.o., Hain LifeScience E.A. Ltd., Hain LifeScience GmbH, Hain LifeScience Solutions (Pty) Ltd., Hain LifeScience Spain S.L., Hain LifeScience UK Ltd., Hain LifeSciences S.A. Pty Ltd., Hydrostatic Extrusions Ltd., Hysitron, InCoaTec GmbH, InVivo Biotech Services GmbH, InVivo Biotech Svs GmbH, JPK Instruments Limited, JPK Instruments USA. Inc., JPK In­stru­ments, JUWE Laborgeraete, Jordan Valley Semiconductors, Keymaster Technologies, Luxendo, Luxendo GmbH, MAC Science, Merlin Diagnostika GmbH, Mestrelab Research S.L., Michrom Bioresources, Oncovision - Innovative Medical Imaging, PMOD Technologies, Prairie Technologies, Princeton Gamma-Tech Instruments Inc, Quantron, RI Research Instruments GmbH, Roentec AG, S.I.S. Surface Imaging Systems, SAS Biocentric, SCiLS GmbH, SkyScan, Socabim, VACUUMSCHMELZE GmbH & Co. KG, Vutara LLC, XGLabs S.r.l., and Yingsheng Technology.
Read More
This page (NASDAQ:BRKR) was last updated on 5/27/2024 by Staff

From Our Partners